Chemours annual debt-to-ebitda ratio
2014
2015
2022
2023
2024
2025
Chemours Debt-to-EBITDA Ratio Growth & History (CC)
Chemours's debt-to-ebitda ratio was 13.35 for fiscal 2025.
View full Chemours company overviewChemours annual debt-to-ebitda ratio history
| Fiscal year | Period ended | Debt-to-EBITDA ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 13.35 | 6.68 | +100.09% |
| 2024 | 2024-12-31 | 6.67 | −15.23 | −69.53% |
| 2023 | 2023-12-31 | 21.90 | 18.61 | +564.19% |
| 2022 | 2022-12-31 | 3.30 | — | — |
| 2015 | 2015-12-31 | 0.81 | 0.81 | — |
| 2014 | 2014-12-31 | 0.00 | — | — |
Chemours quarterly debt-to-ebitda ratio
Q4.15
Q1.16
Q2.16
Q3.16
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-EBITDA ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 7.52 | — | — |
| Q1 2026 | 2026-03-31 | 13.96 | — | — |
| Q3 2016 | 2016-09-30 | 0.78 | — | — |
| Q2 2016 | 2016-06-30 | 0.82 | — | — |
| Q1 2016 | 2016-03-31 | 0.82 | — | — |
| Q4 2015 | 2015-12-31 | 0.81 | — | — |
Chemours debt-to-ebitda ratio trends
Between the periods ended 2014-12-31 and 2025-12-31, Chemours's debt-to-ebitda ratio increased from 0.00 to 13.35, a change of 13.35. The latest reported quarter, Q2 2026, shows 7.52.
About the metric
What the debt-to-EBITDA ratio means
Debt-to-EBITDA compares interest-bearing debt with operating earnings before interest, taxes, depreciation, and amortization. It is commonly used to assess leverage, but it is generally unsuitable for banks and other financial companies.
Calculation and source
How debt-to-EBITDA is calculated
TickerStat divides period-end total debt by annual EBITDA. Quarterly observations use trailing-12-month EBITDA. Periods with zero or negative EBITDA are excluded because the leverage multiple would not be meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Chemours source filings ↗Community posts
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...